AMRX Stock Analysis: Buy, Sell, or Hold?
AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock
$14.25
0.06 (0.42%)
▲
5d:
+3.04%
30d:
+12.56%
90d:
+31.7%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Feb 27, 2026
22d
Get Alerted When AMRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AMRX is fairly valued with market pricing in 3.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: AMRX is fairly valued with market pricing in 3.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.33
Based on 10.8% avg growth
INTRINSIC VALUE TODAY
$13.24
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AMRX is currently trading at $14.25, which is considered extended relative to its 30-day fair value range of $12.86 to $13.79. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.2) compared to its historical average (13.7). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AMRX is in a strong uptrend. Immediate support is located at $13.30, while resistance sits at $15.00.
Market Sentiment: AMRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AMRX is in a strong uptrend. Immediate support is located at $13.30, while resistance sits at $15.00.
Market Sentiment: AMRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$12.86 -
$13.79
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding AMRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.40)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$12.86 -
$13.79
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$13.30
Resistance Level
$15.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
15.21
Wall Street Target
$14.40
(+1.1%)
Revenue Growth (YoY)
11.7%
Earnings Growth (YoY)
261.0%
Profit Margin
0.2%
Valuation Premium vs History
+3.6% premium
PE vs Historical
15.2 vs 13.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$14.76
(+4%)
2-Year Target
$15.29
(+7%)
3-Year Target
$15.85
(+11%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$14.27
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 17.6%)
$33.96
(+138%)
Base:
(SPY PE: 15.2, Growth: 17.6%)
$23.17
(+63%)
Bear:
(PE: 12.9, Growth: 17.6%)
$19.69
(+38%)
📈
Valuation based on Current Earnings
Forward PE: 6.30 | Forward EPS (Implied): $2.26
Bull Case
$17.21
(+21%)
Analyst growth 15.0%, PE expands to 6.6
Base Case
$14.25
(0%)
Market implied 0.0%, PE stable at 6.3
Bear Case
$10.90
(-24%)
Severe decline -15.0%, PE contracts to 5.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 04, 2026 5:50 AM ET
Data refreshes hourly during market hours. Next update: 6:50 AM
Data refreshes hourly during market hours. Next update: 6:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
John Kiely
SELL
32000 shares
2025-08-27
Nikita Shah
SELL
6340 shares
2025-08-25
Nikita Shah
SELL
114492 shares
2025-08-22
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 57 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$37 | 59 HOLD |
Advanced AMRX Option Strategies
Professional options setups generated by AI based on today's AMRX price and gamma walls.
